401k Plan data: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN plan

MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 401k Plan overview

Plan Name	MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN
Plan identification number	001

MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN Benefits

401k Plan Type

Defined Contribution Pension

Plan Features/Benefits

Profit-sharing
ERISA section 404(c) Plan - This plan, or any part of it is intended to meet the conditions of 29 CFR 2550.404c-1.
Total participant-directed account plan - Participants have the opportunity to direct the investment of all the assets allocated to their individual accounts, regardless of whether 29 CFR 2550.404c-1 is intended to be met.
Code section 401(k) feature - A cash or deferred arrangement described in Code section 401(k) that is part of a qualified defined contribution plan that provides for an election by employees to defer part of their compensation or receive these amounts in cash.
Code section 401(m) arrangement - Employee contributions are allocated to separate accounts under the plan or employer contributions are based, in whole or in part, on employee deferrals or contribtions to the plan. Not applicable if plan is 401(k) plan with only QNECs and/or QMACs. Also not applicable if Code section 403(b)(1), 403(b)(7) or 408 arrangements/accounts/annuities.
Plan provides for automatic enrollment in plan that has employee contributions deducted from payroll.
Total or partial participant-directed account plan - plan uses default investment account for participants who fail to direct assets in their account.
Plan covering Self-Employed individuals.
Plan sponsor(s) is (are) a member(s) of a controlled group (Code sections 414(b), (c), or (m)).

401k Sponsoring company profile

MALLINCKRODT ENTERPRISES, LLC has sponsored the creation of one or more 401k plans.

Company Name: MALLINCKRODT ENTERPRISES, LLC

Employer identification number (EIN): 364679061

NAIC Classification: 325410

Additional information about MALLINCKRODT ENTERPRISES, LLC

Jurisdiction of Incorporation: State of Delaware Division of Corporations

Incorporation Date:

Company Identification Number: 4875808

More information about MALLINCKRODT ENTERPRISES, LLC

Form 5500 Filing Information

Submission information for form 5500 for 401k plan MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN

Plan id# Filing Submission Date Name of Administrator Date Administrator Signed Name of Company Sponsor Date Sponsor Signed
001 2019-01-01
001 2018-01-01
001 2017-01-01 BRYAN BIRCH CATHY BEISEL 2018-10-15
001 2016-01-01 BRYAN BIRCH CATHRYN K. BEISEL 2017-10-09
001 2015-01-01 CATHRYN BEISEL BRYAN BIRCH 2016-10-13
001 2014-01-01 CATHRYN BEISEL BRYAN BIRCH 2015-10-14
001 2013-04-01 BRYAN BIRCH BRYAN BIRCH 2014-07-21

Plan id#	Filing Submission Date	Name of Administrator	Name of Company Sponsor	Date Sponsor Signed
001	2019-01-01
001	2018-01-01
001	2017-01-01	BRYAN BIRCH	CATHY BEISEL	2018-10-15
001	2016-01-01	BRYAN BIRCH	CATHRYN K. BEISEL	2017-10-09
001	2015-01-01	CATHRYN BEISEL	BRYAN BIRCH	2016-10-13
001	2014-01-01	CATHRYN BEISEL	BRYAN BIRCH	2015-10-14
001	2013-04-01	BRYAN BIRCH	BRYAN BIRCH	2014-07-21

Plan Statistics for MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN

401k plan membership statisitcs for MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN

Measure Date Value
2019: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2019 401k membership
Total participants, beginning-of-year 2019-01-01 4,602
Total number of active participants reported on line 7a of the Form 5500 2019-01-01 3,093
Number of retired or separated participants receiving benefits 2019-01-01 19
Number of other retired or separated participants entitled to future benefits 2019-01-01 1,249
Total of all active and inactive participants 2019-01-01 4,361
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2019-01-01 2
Total participants 2019-01-01 4,363
Number of participants with account balances 2019-01-01 4,357
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2019-01-01 135
2018: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2018 401k membership
Total participants, beginning-of-year 2018-01-01 4,485
Total number of active participants reported on line 7a of the Form 5500 2018-01-01 3,590
Number of retired or separated participants receiving benefits 2018-01-01 13
Number of other retired or separated participants entitled to future benefits 2018-01-01 997
Total of all active and inactive participants 2018-01-01 4,600
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2018-01-01 2
Total participants 2018-01-01 4,602
Number of participants with account balances 2018-01-01 4,399
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2018-01-01 133
2017: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2017 401k membership
Total participants, beginning-of-year 2017-01-01 5,356
Total number of active participants reported on line 7a of the Form 5500 2017-01-01 3,338
Number of retired or separated participants receiving benefits 2017-01-01 0
Number of other retired or separated participants entitled to future benefits 2017-01-01 1,147
Total of all active and inactive participants 2017-01-01 4,485
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2017-01-01 0
Total participants 2017-01-01 4,485
Number of participants with account balances 2017-01-01 4,483
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2017-01-01 13
2016: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2016 401k membership
Total participants, beginning-of-year 2016-01-01 5,362
Total number of active participants reported on line 7a of the Form 5500 2016-01-01 3,899
Number of retired or separated participants receiving benefits 2016-01-01 8
Number of other retired or separated participants entitled to future benefits 2016-01-01 1,448
Total of all active and inactive participants 2016-01-01 5,355
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2016-01-01 1
Total participants 2016-01-01 5,356
Number of participants with account balances 2016-01-01 5,338
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2016-01-01 134
2015: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2015 401k membership
Total participants, beginning-of-year 2015-01-01 5,025
Total number of active participants reported on line 7a of the Form 5500 2015-01-01 4,001
Number of retired or separated participants receiving benefits 2015-01-01 3
Number of other retired or separated participants entitled to future benefits 2015-01-01 1,357
Total of all active and inactive participants 2015-01-01 5,361
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2015-01-01 1
Total participants 2015-01-01 5,362
Number of participants with account balances 2015-01-01 5,330
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2015-01-01 159
2014: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2014 401k membership
Total participants, beginning-of-year 2014-01-01 4,634
Total number of active participants reported on line 7a of the Form 5500 2014-01-01 4,191
Number of retired or separated participants receiving benefits 2014-01-01 3
Number of other retired or separated participants entitled to future benefits 2014-01-01 831
Total of all active and inactive participants 2014-01-01 5,025
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2014-01-01 0
Total participants 2014-01-01 5,025
Number of participants with account balances 2014-01-01 4,428
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2014-01-01 107
2013: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2013 401k membership
Total participants, beginning-of-year 2013-04-01 4,288
Total number of active participants reported on line 7a of the Form 5500 2013-04-01 4,153
Number of retired or separated participants receiving benefits 2013-04-01 0
Number of other retired or separated participants entitled to future benefits 2013-04-01 481
Total of all active and inactive participants 2013-04-01 4,634
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits 2013-04-01 0
Total participants 2013-04-01 4,634
Number of participants with account balances 2013-04-01 4,594
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested 2013-04-01 123

Measure	Date	Value
2019: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2019 401k membership
Total participants, beginning-of-year	2019-01-01	4,602
Total number of active participants reported on line 7a of the Form 5500	2019-01-01	3,093
Number of retired or separated participants receiving benefits	2019-01-01	19
Number of other retired or separated participants entitled to future benefits	2019-01-01	1,249
Total of all active and inactive participants	2019-01-01	4,361
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2019-01-01	2
Total participants	2019-01-01	4,363
Number of participants with account balances	2019-01-01	4,357
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2019-01-01	135
2018: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2018 401k membership
Total participants, beginning-of-year	2018-01-01	4,485
Total number of active participants reported on line 7a of the Form 5500	2018-01-01	3,590
Number of retired or separated participants receiving benefits	2018-01-01	13
Number of other retired or separated participants entitled to future benefits	2018-01-01	997
Total of all active and inactive participants	2018-01-01	4,600
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2018-01-01	2
Total participants	2018-01-01	4,602
Number of participants with account balances	2018-01-01	4,399
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2018-01-01	133
2017: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2017 401k membership
Total participants, beginning-of-year	2017-01-01	5,356
Total number of active participants reported on line 7a of the Form 5500	2017-01-01	3,338
Number of retired or separated participants receiving benefits	2017-01-01	0
Number of other retired or separated participants entitled to future benefits	2017-01-01	1,147
Total of all active and inactive participants	2017-01-01	4,485
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2017-01-01	0
Total participants	2017-01-01	4,485
Number of participants with account balances	2017-01-01	4,483
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2017-01-01	13
2016: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2016 401k membership
Total participants, beginning-of-year	2016-01-01	5,362
Total number of active participants reported on line 7a of the Form 5500	2016-01-01	3,899
Number of retired or separated participants receiving benefits	2016-01-01	8
Number of other retired or separated participants entitled to future benefits	2016-01-01	1,448
Total of all active and inactive participants	2016-01-01	5,355
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2016-01-01	1
Total participants	2016-01-01	5,356
Number of participants with account balances	2016-01-01	5,338
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2016-01-01	134
2015: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2015 401k membership
Total participants, beginning-of-year	2015-01-01	5,025
Total number of active participants reported on line 7a of the Form 5500	2015-01-01	4,001
Number of retired or separated participants receiving benefits	2015-01-01	3
Number of other retired or separated participants entitled to future benefits	2015-01-01	1,357
Total of all active and inactive participants	2015-01-01	5,361
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2015-01-01	1
Total participants	2015-01-01	5,362
Number of participants with account balances	2015-01-01	5,330
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2015-01-01	159
2014: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2014 401k membership
Total participants, beginning-of-year	2014-01-01	4,634
Total number of active participants reported on line 7a of the Form 5500	2014-01-01	4,191
Number of retired or separated participants receiving benefits	2014-01-01	3
Number of other retired or separated participants entitled to future benefits	2014-01-01	831
Total of all active and inactive participants	2014-01-01	5,025
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2014-01-01	0
Total participants	2014-01-01	5,025
Number of participants with account balances	2014-01-01	4,428
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2014-01-01	107
2013: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2013 401k membership
Total participants, beginning-of-year	2013-04-01	4,288
Total number of active participants reported on line 7a of the Form 5500	2013-04-01	4,153
Number of retired or separated participants receiving benefits	2013-04-01	0
Number of other retired or separated participants entitled to future benefits	2013-04-01	481
Total of all active and inactive participants	2013-04-01	4,634
Number of deceased participants whose beneficiaries are receiving or are entitled to receive benefits	2013-04-01	0
Total participants	2013-04-01	4,634
Number of participants with account balances	2013-04-01	4,594
Participants that terminated employment during the plan year with accrued benefits that were less than 100% vested	2013-04-01	123

Financial Data on MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN

Measure	Date	Value
2019 : MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2019 401k financial data
Unrealized appreciation/depreciation of real estate assets	2019-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2019-12-31	$0
Total unrealized appreciation/depreciation of assets	2019-12-31	$0
Total transfer of assets to this plan	2019-12-31	$9,344,314
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2019-12-31	$0
Expenses. Interest paid	2019-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2019-12-31	$0
Total income from all sources (including contributions)	2019-12-31	$205,887,916
Total loss/gain on sale of assets	2019-12-31	$0
Total of all expenses incurred	2019-12-31	$106,076,500
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2019-12-31	$105,970,788
Expenses. Certain deemed distributions of participant loans	2019-12-31	$-17,711
Value of total corrective distributions	2019-12-31	$22,092
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2019-12-31	$60,389,818
Value of total assets at end of year	2019-12-31	$756,595,853
Value of total assets at beginning of year	2019-12-31	$647,440,123
Total of administrative expenses incurred including professional, contract, advisory and management fees	2019-12-31	$101,331
Total income from rents	2019-12-31	$0
Total interest from all sources	2019-12-31	$1,107,897
Total dividends received (eg from common stock, registered investment company shares)	2019-12-31	$9,794,486
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2019-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2019-12-31	$9,794,486
Assets. Real estate other than employer real property at end of year	2019-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2019-12-31	$0
Administrative expenses professional fees incurred	2019-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2019-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2019-12-31	$0
Was this plan covered by a fidelity bond	2019-12-31	Yes
Value of fidelity bond cover	2019-12-31	$15,000,000
If this is an individual account plan, was there a blackout period	2019-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2019-12-31	No
Contributions received from participants	2019-12-31	$35,304,233
Participant contributions at end of year	2019-12-31	$12,447,313
Participant contributions at beginning of year	2019-12-31	$12,473,466
Participant contributions at end of year	2019-12-31	$0
Participant contributions at beginning of year	2019-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2019-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2019-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2019-12-31	$5,754,454
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2019-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2019-12-31	$0
Assets. Loans (other than to participants) at end of year	2019-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2019-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2019-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2019-12-31	$0
Other income not declared elsewhere	2019-12-31	$0
Administrative expenses (other) incurred	2019-12-31	$101,331
Liabilities. Value of operating payables at end of year	2019-12-31	$0
Liabilities. Value of operating payables at beginning of year	2019-12-31	$0
Total non interest bearing cash at end of year	2019-12-31	$0
Total non interest bearing cash at beginning of year	2019-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Income. Non cash contributions	2019-12-31	$0
Value of net income/loss	2019-12-31	$99,811,416
Value of net assets at end of year (total assets less liabilities)	2019-12-31	$756,595,853
Value of net assets at beginning of year (total assets less liabilities)	2019-12-31	$647,440,123
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2019-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2019-12-31	No
Were any leases to which the plan was party in default or uncollectible	2019-12-31	No
Assets. partnership/joint venture interests at end of year	2019-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2019-12-31	$0
Investment advisory and management fees	2019-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2019-12-31	$392,570,614
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2019-12-31	$341,915,334
Value of interest in pooled separate accounts at end of year	2019-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2019-12-31	$0
Interest on participant loans	2019-12-31	$601,300
Income. Interest from loans (other than to participants)	2019-12-31	$0
Interest earned on other investments	2019-12-31	$0
Income. Interest from US Government securities	2019-12-31	$0
Income. Interest from corporate debt instruments	2019-12-31	$0
Value of interest in master investment trust accounts at end of year	2019-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2019-12-31	$0
Value of interest in common/collective trusts at end of year	2019-12-31	$326,398,119
Value of interest in common/collective trusts at beginning of year	2019-12-31	$270,548,251
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2019-12-31	$23,890,307
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2019-12-31	$21,271,724
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2019-12-31	$21,271,724
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2019-12-31	$506,597
Assets. Value of investments in 103.12 investment entities at end of year	2019-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2019-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2019-12-31	$0
Asset value of US Government securities at end of year	2019-12-31	$0
Asset value of US Government securities at beginning of year	2019-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2019-12-31	$75,750,371
Net investment gain/loss from pooled separate accounts	2019-12-31	$0
Net investment gain or loss from common/collective trusts	2019-12-31	$58,845,344
Net gain/loss from 103.12 investment entities	2019-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2019-12-31	No
Was there a failure to transmit to the plan any participant contributions	2019-12-31	No
Has the plan failed to provide any benefit when due under the plan	2019-12-31	No
Assets. Invements in employer securities at end of year	2019-12-31	$0
Assets. Invements in employer securities at beginning of year	2019-12-31	$0
Assets. Value of employer real property at end of year	2019-12-31	$0
Assets. Value of employer real property at beginning of year	2019-12-31	$0
Contributions received in cash from employer	2019-12-31	$19,331,131
Employer contributions (assets) at end of year	2019-12-31	$1,289,500
Employer contributions (assets) at beginning of year	2019-12-31	$1,231,348
Income. Dividends from preferred stock	2019-12-31	$0
Income. Dividends from common stock	2019-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2019-12-31	$105,970,788
Asset. Corporate debt instrument preferred debt at end of year	2019-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2019-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2019-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2019-12-31	$0
Contract administrator fees	2019-12-31	$0
Assets. Corporate common stocks other than exployer securities at end of year	2019-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2019-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2019-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2019-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2019-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2019-12-31	$0
Did the plan have assets held for investment	2019-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2019-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2019-12-31	No
Aggregate proceeds on sale of assets	2019-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2019-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2019-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2019-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2019-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2019-12-31	Disclaimer
Accountancy firm name	2019-12-31	BROWN SMITH WALLACE LLP
Accountancy firm EIN	2019-12-31	431001367
2018 : MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2018 401k financial data
Unrealized appreciation/depreciation of real estate assets	2018-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2018-12-31	$0
Total unrealized appreciation/depreciation of assets	2018-12-31	$0
Total transfer of assets to this plan	2018-12-31	$0
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2018-12-31	$0
Expenses. Interest paid	2018-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2018-12-31	$0
Total income from all sources (including contributions)	2018-12-31	$28,911,192
Total loss/gain on sale of assets	2018-12-31	$0
Total of all expenses incurred	2018-12-31	$97,121,209
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2018-12-31	$97,018,689
Expenses. Certain deemed distributions of participant loans	2018-12-31	$109,444
Value of total corrective distributions	2018-12-31	$738
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2018-12-31	$63,212,598
Value of total assets at end of year	2018-12-31	$647,440,123
Value of total assets at beginning of year	2018-12-31	$715,650,140
Total of administrative expenses incurred including professional, contract, advisory and management fees	2018-12-31	$-7,662
Total income from rents	2018-12-31	$0
Total interest from all sources	2018-12-31	$883,224
Total dividends received (eg from common stock, registered investment company shares)	2018-12-31	$16,125,911
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2018-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2018-12-31	$16,125,911
Assets. Real estate other than employer real property at end of year	2018-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2018-12-31	$0
Administrative expenses professional fees incurred	2018-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2018-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2018-12-31	$0
Was this plan covered by a fidelity bond	2018-12-31	Yes
Value of fidelity bond cover	2018-12-31	$15,000,000
If this is an individual account plan, was there a blackout period	2018-12-31	No
Were there any nonexempt tranactions with any party-in-interest	2018-12-31	No
Contributions received from participants	2018-12-31	$35,522,052
Participant contributions at end of year	2018-12-31	$12,473,466
Participant contributions at beginning of year	2018-12-31	$12,846,829
Participant contributions at end of year	2018-12-31	$0
Participant contributions at beginning of year	2018-12-31	$70,491
Assets. Other investments not covered elsewhere at end of year	2018-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2018-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2018-12-31	$4,077,378
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2018-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2018-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2018-12-31	$0
Assets. Loans (other than to participants) at end of year	2018-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2018-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2018-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2018-12-31	$0
Other income not declared elsewhere	2018-12-31	$0
Administrative expenses (other) incurred	2018-12-31	$-7,662
Liabilities. Value of operating payables at end of year	2018-12-31	$0
Liabilities. Value of operating payables at beginning of year	2018-12-31	$0
Total non interest bearing cash at end of year	2018-12-31	$0
Total non interest bearing cash at beginning of year	2018-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Income. Non cash contributions	2018-12-31	$0
Value of net income/loss	2018-12-31	$-68,210,017
Value of net assets at end of year (total assets less liabilities)	2018-12-31	$647,440,123
Value of net assets at beginning of year (total assets less liabilities)	2018-12-31	$715,650,140
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2018-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2018-12-31	No
Were any leases to which the plan was party in default or uncollectible	2018-12-31	No
Assets. partnership/joint venture interests at end of year	2018-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2018-12-31	$0
Investment advisory and management fees	2018-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2018-12-31	$341,915,334
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2018-12-31	$401,550,465
Value of interest in pooled separate accounts at end of year	2018-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2018-12-31	$0
Interest on participant loans	2018-12-31	$508,467
Income. Interest from loans (other than to participants)	2018-12-31	$0
Interest earned on other investments	2018-12-31	$0
Income. Interest from US Government securities	2018-12-31	$0
Income. Interest from corporate debt instruments	2018-12-31	$0
Value of interest in master investment trust accounts at end of year	2018-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2018-12-31	$0
Value of interest in common/collective trusts at end of year	2018-12-31	$270,548,251
Value of interest in common/collective trusts at beginning of year	2018-12-31	$301,129,818
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2018-12-31	$21,271,724
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2018-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2018-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2018-12-31	$374,757
Assets. Value of investments in 103.12 investment entities at end of year	2018-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2018-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2018-12-31	$0
Asset value of US Government securities at end of year	2018-12-31	$0
Asset value of US Government securities at beginning of year	2018-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2018-12-31	$-33,586,233
Net investment gain/loss from pooled separate accounts	2018-12-31	$0
Net investment gain or loss from common/collective trusts	2018-12-31	$-17,724,308
Net gain/loss from 103.12 investment entities	2018-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2018-12-31	No
Was there a failure to transmit to the plan any participant contributions	2018-12-31	No
Has the plan failed to provide any benefit when due under the plan	2018-12-31	No
Assets. Invements in employer securities at end of year	2018-12-31	$0
Assets. Invements in employer securities at beginning of year	2018-12-31	$0
Assets. Value of employer real property at end of year	2018-12-31	$0
Assets. Value of employer real property at beginning of year	2018-12-31	$0
Contributions received in cash from employer	2018-12-31	$23,613,168
Employer contributions (assets) at end of year	2018-12-31	$1,231,348
Employer contributions (assets) at beginning of year	2018-12-31	$52,537
Income. Dividends from preferred stock	2018-12-31	$0
Income. Dividends from common stock	2018-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2018-12-31	$97,018,689
Asset. Corporate debt instrument preferred debt at end of year	2018-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2018-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2018-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2018-12-31	$0
Contract administrator fees	2018-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2018-12-31	No
Assets. Corporate common stocks other than exployer securities at end of year	2018-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2018-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2018-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2018-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2018-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2018-12-31	$0
Did the plan have assets held for investment	2018-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2018-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2018-12-31	No
Aggregate proceeds on sale of assets	2018-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2018-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2018-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2018-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2018-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2018-12-31	Disclaimer
Accountancy firm name	2018-12-31	BROWN SMITH WALLACE LLP
Accountancy firm EIN	2018-12-31	431001367
2017 : MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2017 401k financial data
Unrealized appreciation/depreciation of real estate assets	2017-12-31	$0
Unrealized appreciation/depreciation of other (non real estate) assets	2017-12-31	$0
Total unrealized appreciation/depreciation of assets	2017-12-31	$0
Total transfer of assets to this plan	2017-12-31	$3,907,053
Total transfer of assets from this plan	2017-12-31	$1,211,964
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2017-12-31	$0
Expenses. Interest paid	2017-12-31	$0
Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102	2017-12-31	$0
Total income from all sources (including contributions)	2017-12-31	$179,518,882
Total loss/gain on sale of assets	2017-12-31	$0
Total of all expenses incurred	2017-12-31	$123,294,536
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2017-12-31	$123,095,375
Expenses. Certain deemed distributions of participant loans	2017-12-31	$0
Value of total corrective distributions	2017-12-31	$38,658
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2017-12-31	$67,305,527
Value of total assets at end of year	2017-12-31	$715,650,140
Value of total assets at beginning of year	2017-12-31	$656,730,705
Total of administrative expenses incurred including professional, contract, advisory and management fees	2017-12-31	$160,503
Total income from rents	2017-12-31	$0
Total interest from all sources	2017-12-31	$571,298
Total dividends received (eg from common stock, registered investment company shares)	2017-12-31	$14,974,550
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2017-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2017-12-31	$14,974,550
Assets. Real estate other than employer real property at end of year	2017-12-31	$0
Assets. Real estate other than employer real property at beginning of year	2017-12-31	$0
Administrative expenses professional fees incurred	2017-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at end of year	2017-12-31	$0
Assets. Corporate prefeered stocks other than exployer securities at beginning of year	2017-12-31	$0
Was this plan covered by a fidelity bond	2017-12-31	Yes
Value of fidelity bond cover	2017-12-31	$15,000,000
If this is an individual account plan, was there a blackout period	2017-12-31	Yes
Were there any nonexempt tranactions with any party-in-interest	2017-12-31	No
Contributions received from participants	2017-12-31	$35,553,152
Participant contributions at end of year	2017-12-31	$12,846,829
Participant contributions at beginning of year	2017-12-31	$13,755,343
Participant contributions at end of year	2017-12-31	$70,491
Participant contributions at beginning of year	2017-12-31	$0
Assets. Other investments not covered elsewhere at end of year	2017-12-31	$0
Assets. Other investments not covered elsewhere at beginning of year	2017-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2017-12-31	$7,801,888
Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries)	2017-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at end of year	2017-12-31	$0
Value of other receiveables (less allowance for doubtful accounts) at beginning of year	2017-12-31	$0
Assets. Loans (other than to participants) at end of year	2017-12-31	$0
Assets. Loans (other than to participants) at beginning of year	2017-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2017-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2017-12-31	$0
Other income not declared elsewhere	2017-12-31	$0
Administrative expenses (other) incurred	2017-12-31	$160,503
Liabilities. Value of operating payables at end of year	2017-12-31	$0
Liabilities. Value of operating payables at beginning of year	2017-12-31	$0
Total non interest bearing cash at end of year	2017-12-31	$0
Total non interest bearing cash at beginning of year	2017-12-31	$0
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Income. Non cash contributions	2017-12-31	$0
Value of net income/loss	2017-12-31	$56,224,346
Value of net assets at end of year (total assets less liabilities)	2017-12-31	$715,650,140
Value of net assets at beginning of year (total assets less liabilities)	2017-12-31	$656,730,705
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2017-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2017-12-31	No
Were any leases to which the plan was party in default or uncollectible	2017-12-31	No
Assets. partnership/joint venture interests at end of year	2017-12-31	$0
Assets. partnership/joint venture interests at beginning of year	2017-12-31	$0
Investment advisory and management fees	2017-12-31	$0
Value of interest in registered invesment companies (eg mutual funds) at end of year	2017-12-31	$401,550,465
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2017-12-31	$367,691,580
Value of interest in pooled separate accounts at end of year	2017-12-31	$0
Value of interest in pooled separate accounts at beginning of year	2017-12-31	$0
Interest on participant loans	2017-12-31	$571,298
Income. Interest from loans (other than to participants)	2017-12-31	$0
Interest earned on other investments	2017-12-31	$0
Income. Interest from US Government securities	2017-12-31	$0
Income. Interest from corporate debt instruments	2017-12-31	$0
Value of interest in master investment trust accounts at end of year	2017-12-31	$0
Value of interest in master investment trust accounts at beginning of year	2017-12-31	$0
Value of interest in common/collective trusts at end of year	2017-12-31	$301,129,818
Value of interest in common/collective trusts at beginning of year	2017-12-31	$275,283,782
Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year	2017-12-31	$0
Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year	2017-12-31	$0
Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year	2017-12-31	$0
Interest earned from interest bearing cash (including money market accounts and certificates of deposit)	2017-12-31	$0
Assets. Value of investments in 103.12 investment entities at end of year	2017-12-31	$0
Assets. Value of investments in 103.12 investment entities at beginning of year	2017-12-31	$0
Expenses. Payments to insurance carriers foe the provision of benefits	2017-12-31	$0
Asset value of US Government securities at end of year	2017-12-31	$0
Asset value of US Government securities at beginning of year	2017-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2017-12-31	$0
Net investment gain/loss from pooled separate accounts	2017-12-31	$0
Net investment gain or loss from common/collective trusts	2017-12-31	$96,667,507
Net gain/loss from 103.12 investment entities	2017-12-31	$0
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2017-12-31	No
Was there a failure to transmit to the plan any participant contributions	2017-12-31	No
Has the plan failed to provide any benefit when due under the plan	2017-12-31	No
Assets. Invements in employer securities at end of year	2017-12-31	$0
Assets. Invements in employer securities at beginning of year	2017-12-31	$0
Assets. Value of employer real property at end of year	2017-12-31	$0
Assets. Value of employer real property at beginning of year	2017-12-31	$0
Contributions received in cash from employer	2017-12-31	$23,950,487
Employer contributions (assets) at end of year	2017-12-31	$52,537
Employer contributions (assets) at beginning of year	2017-12-31	$0
Income. Dividends from preferred stock	2017-12-31	$0
Income. Dividends from common stock	2017-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2017-12-31	$123,095,375
Asset. Corporate debt instrument preferred debt at end of year	2017-12-31	$0
Asset. Corporate debt instrument preferred debt at beginning of year	2017-12-31	$0
Asset. Corporate debt instrument debt (other) at end of year	2017-12-31	$0
Asset. Corporate debt instrument debt (other) at beginning of year	2017-12-31	$0
Contract administrator fees	2017-12-31	$0
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2017-12-31	Yes
Assets. Corporate common stocks other than exployer securities at end of year	2017-12-31	$0
Assets. Corporate common stocks other than exployer securities at beginning of year	2017-12-31	$0
Liabilities. Value of benefit claims payable at end of year	2017-12-31	$0
Liabilities. Value of benefit claims payable at beginning of year	2017-12-31	$0
Assets. Value of buildings and other operty used in plan operation at end of year	2017-12-31	$0
Assets. Value of buildings and other operty used in plan operation at beginning of year	2017-12-31	$0
Did the plan have assets held for investment	2017-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2017-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2017-12-31	No
Aggregate proceeds on sale of assets	2017-12-31	$0
Aggregate carrying amount (costs) on sale of assets	2017-12-31	$0
Liabilities. Value of acquisition indebtedness at end of year	2017-12-31	$0
Liabilities. Value of acquisition indebtedness at beginning of year	2017-12-31	$0
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2017-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2017-12-31	Disclaimer
Accountancy firm name	2017-12-31	BROWN SMITH WALLACE LLP
Accountancy firm EIN	2017-12-31	431001367
2016 : MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2016 401k financial data
Total unrealized appreciation/depreciation of assets	2016-12-31	$0
Total transfer of assets to this plan	2016-12-31	$43,843,464
Total transfer of assets from this plan	2016-12-31	$49,368
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2016-12-31	$0
Total income from all sources (including contributions)	2016-12-31	$126,346,474
Total loss/gain on sale of assets	2016-12-31	$0
Total of all expenses incurred	2016-12-31	$86,277,258
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2016-12-31	$85,910,278
Expenses. Certain deemed distributions of participant loans	2016-12-31	$273,802
Value of total corrective distributions	2016-12-31	$41,154
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2016-12-31	$80,919,634
Value of total assets at end of year	2016-12-31	$656,730,705
Value of total assets at beginning of year	2016-12-31	$572,867,393
Total of administrative expenses incurred including professional, contract, advisory and management fees	2016-12-31	$52,024
Total interest from all sources	2016-12-31	$505,344
Total dividends received (eg from common stock, registered investment company shares)	2016-12-31	$9,783,264
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2016-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2016-12-31	$9,783,264
Was this plan covered by a fidelity bond	2016-12-31	Yes
Value of fidelity bond cover	2016-12-31	$15,000,000
If this is an individual account plan, was there a blackout period	2016-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2016-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2016-12-31	No
Contributions received from participants	2016-12-31	$37,470,224
Participant contributions at end of year	2016-12-31	$13,755,343
Participant contributions at beginning of year	2016-12-31	$12,571,797
Participant contributions at end of year	2016-12-31	$0
Participant contributions at beginning of year	2016-12-31	$70,751
Income. Received or receivable in cash from other sources (including rollovers)	2016-12-31	$17,723,547
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2016-12-31	$0
Other income not declared elsewhere	2016-12-31	$650
Administrative expenses (other) incurred	2016-12-31	$52,024
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Value of net income/loss	2016-12-31	$40,069,216
Value of net assets at end of year (total assets less liabilities)	2016-12-31	$656,730,705
Value of net assets at beginning of year (total assets less liabilities)	2016-12-31	$572,867,393
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2016-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2016-12-31	No
Were any leases to which the plan was party in default or uncollectible	2016-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2016-12-31	$367,691,580
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2016-12-31	$356,334,388
Interest on participant loans	2016-12-31	$505,344
Value of interest in common/collective trusts at end of year	2016-12-31	$275,283,782
Value of interest in common/collective trusts at beginning of year	2016-12-31	$203,835,484
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2016-12-31	$15,775,483
Net investment gain or loss from common/collective trusts	2016-12-31	$19,362,099
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2016-12-31	No
Was there a failure to transmit to the plan any participant contributions	2016-12-31	No
Has the plan failed to provide any benefit when due under the plan	2016-12-31	No
Contributions received in cash from employer	2016-12-31	$25,725,863
Employer contributions (assets) at end of year	2016-12-31	$0
Employer contributions (assets) at beginning of year	2016-12-31	$54,973
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2016-12-31	$85,910,278
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2016-12-31	Yes
Did the plan have assets held for investment	2016-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2016-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2016-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2016-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2016-12-31	Disclaimer
Accountancy firm name	2016-12-31	BROWN SMITH WALLACE LLP
Accountancy firm EIN	2016-12-31	431001367
2015 : MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2015 401k financial data
Total unrealized appreciation/depreciation of assets	2015-12-31	$0
Total transfer of assets to this plan	2015-12-31	$30,715,767
Total transfer of assets from this plan	2015-12-31	$916,310
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2015-12-31	$3,375
Total income from all sources (including contributions)	2015-12-31	$73,940,727
Total loss/gain on sale of assets	2015-12-31	$0
Total of all expenses incurred	2015-12-31	$91,204,863
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2015-12-31	$90,951,446
Expenses. Certain deemed distributions of participant loans	2015-12-31	$12,028
Value of total corrective distributions	2015-12-31	$3,907
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2015-12-31	$69,892,477
Value of total assets at end of year	2015-12-31	$572,867,393
Value of total assets at beginning of year	2015-12-31	$560,335,447
Total of administrative expenses incurred including professional, contract, advisory and management fees	2015-12-31	$237,482
Total interest from all sources	2015-12-31	$496,616
Total dividends received (eg from common stock, registered investment company shares)	2015-12-31	$11,366,252
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2015-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2015-12-31	$11,366,252
Was this plan covered by a fidelity bond	2015-12-31	Yes
Value of fidelity bond cover	2015-12-31	$15,000,000
If this is an individual account plan, was there a blackout period	2015-12-31	Yes
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2015-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2015-12-31	No
Contributions received from participants	2015-12-31	$36,841,809
Participant contributions at end of year	2015-12-31	$12,571,797
Participant contributions at beginning of year	2015-12-31	$13,816,702
Participant contributions at end of year	2015-12-31	$70,751
Participant contributions at beginning of year	2015-12-31	$78,813
Income. Received or receivable in cash from other sources (including rollovers)	2015-12-31	$6,880,383
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2015-12-31	$0
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year	2015-12-31	$3,375
Other income not declared elsewhere	2015-12-31	$23,859
Administrative expenses (other) incurred	2015-12-31	$237,482
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Value of net income/loss	2015-12-31	$-17,264,136
Value of net assets at end of year (total assets less liabilities)	2015-12-31	$572,867,393
Value of net assets at beginning of year (total assets less liabilities)	2015-12-31	$560,332,072
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2015-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2015-12-31	No
Were any leases to which the plan was party in default or uncollectible	2015-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2015-12-31	$356,334,388
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2015-12-31	$365,124,803
Interest on participant loans	2015-12-31	$496,616
Value of interest in common/collective trusts at end of year	2015-12-31	$203,835,484
Value of interest in common/collective trusts at beginning of year	2015-12-31	$181,257,644
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2015-12-31	$-4,549,535
Net investment gain or loss from common/collective trusts	2015-12-31	$-3,288,942
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2015-12-31	No
Was there a failure to transmit to the plan any participant contributions	2015-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2015-12-31	No
Contributions received in cash from employer	2015-12-31	$26,170,285
Employer contributions (assets) at end of year	2015-12-31	$54,973
Employer contributions (assets) at beginning of year	2015-12-31	$57,485
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2015-12-31	$90,951,446
Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3	2015-12-31	Yes
Did the plan have assets held for investment	2015-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2015-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2015-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2015-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2015-12-31	Disclaimer
Accountancy firm name	2015-12-31	BROWN SMITH WALLACE LLP
Accountancy firm EIN	2015-12-31	431001367
2014 : MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2014 401k financial data
Total unrealized appreciation/depreciation of assets	2014-12-31	$0
Total transfer of assets to this plan	2014-12-31	$12,012,145
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$3,375
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2014-12-31	$0
Total income from all sources (including contributions)	2014-12-31	$85,234,535
Total loss/gain on sale of assets	2014-12-31	$0
Total of all expenses incurred	2014-12-31	$56,646,765
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2014-12-31	$55,784,218
Expenses. Certain deemed distributions of participant loans	2014-12-31	$509,644
Value of total corrective distributions	2014-12-31	$3,592
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2014-12-31	$51,703,777
Value of total assets at end of year	2014-12-31	$560,335,447
Value of total assets at beginning of year	2014-12-31	$519,732,157
Total of administrative expenses incurred including professional, contract, advisory and management fees	2014-12-31	$349,311
Total interest from all sources	2014-12-31	$514,570
Total dividends received (eg from common stock, registered investment company shares)	2014-12-31	$12,897,040
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2014-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2014-12-31	$12,897,040
Was this plan covered by a fidelity bond	2014-12-31	Yes
Value of fidelity bond cover	2014-12-31	$10,000,000
If this is an individual account plan, was there a blackout period	2014-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2014-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2014-12-31	No
Contributions received from participants	2014-12-31	$28,831,382
Participant contributions at end of year	2014-12-31	$13,816,702
Participant contributions at beginning of year	2014-12-31	$14,210,580
Participant contributions at end of year	2014-12-31	$78,813
Participant contributions at beginning of year	2014-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2014-12-31	$1,722,348
Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year	2014-12-31	$3,375
Other income not declared elsewhere	2014-12-31	$1,069
Administrative expenses (other) incurred	2014-12-31	$349,311
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Value of net income/loss	2014-12-31	$28,587,770
Value of net assets at end of year (total assets less liabilities)	2014-12-31	$560,332,072
Value of net assets at beginning of year (total assets less liabilities)	2014-12-31	$519,732,157
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2014-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2014-12-31	No
Were any leases to which the plan was party in default or uncollectible	2014-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2014-12-31	$365,124,803
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2014-12-31	$347,330,648
Interest on participant loans	2014-12-31	$514,570
Value of interest in common/collective trusts at end of year	2014-12-31	$181,257,644
Value of interest in common/collective trusts at beginning of year	2014-12-31	$158,185,919
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2014-12-31	$10,935,713
Net investment gain or loss from common/collective trusts	2014-12-31	$9,182,366
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2014-12-31	No
Was there a failure to transmit to the plan any participant contributions	2014-12-31	Yes
Has the plan failed to provide any benefit when due under the plan	2014-12-31	No
Contributions received in cash from employer	2014-12-31	$21,150,047
Employer contributions (assets) at end of year	2014-12-31	$57,485
Employer contributions (assets) at beginning of year	2014-12-31	$5,010
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2014-12-31	$55,784,218
Did the plan have assets held for investment	2014-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2014-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2014-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2014-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2014-12-31	Disclaimer
Accountancy firm name	2014-12-31	BROWN SMITH WALLACE LLC
Accountancy firm EIN	2014-12-31	431001367
2013 : MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2013 401k financial data
Total unrealized appreciation/depreciation of assets	2013-12-31	$0
Total transfer of assets to this plan	2013-12-31	$455,235,859
Total transfer of assets from this plan	2013-12-31	$366,701
Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities)	2013-12-31	$0
Total income from all sources (including contributions)	2013-12-31	$98,977,966
Total loss/gain on sale of assets	2013-12-31	$0
Total of all expenses incurred	2013-12-31	$34,114,967
Benefit payments and payments to participlants,beneficiaries,insurance carriers and others	2013-12-31	$33,223,516
Expenses. Certain deemed distributions of participant loans	2013-12-31	$776,593
Value of total corrective distributions	2013-12-31	$5,260
Total contributions o plan (from employers,participants, others, non cash contrinutions)	2013-12-31	$40,054,380
Value of total assets at end of year	2013-12-31	$519,732,157
Value of total assets at beginning of year	2013-12-31	$0
Total of administrative expenses incurred including professional, contract, advisory and management fees	2013-12-31	$109,598
Total interest from all sources	2013-12-31	$375,889
Total dividends received (eg from common stock, registered investment company shares)	2013-12-31	$7,829,653
Has a resolution to terminate the plan been adopted during the plan year or any prior plan year	2013-12-31	No
Total dividends received from registered investment company shares (eg mutual funds)	2013-12-31	$7,829,653
Was this plan covered by a fidelity bond	2013-12-31	Yes
Value of fidelity bond cover	2013-12-31	$15,000,000
If this is an individual account plan, was there a blackout period	2013-12-31	No
Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities	2013-12-31	$0
Were there any nonexempt tranactions with any party-in-interest	2013-12-31	No
Contributions received from participants	2013-12-31	$22,411,535
Participant contributions at end of year	2013-12-31	$14,210,580
Participant contributions at beginning of year	2013-12-31	$0
Income. Received or receivable in cash from other sources (including rollovers)	2013-12-31	$1,158,867
Other income not declared elsewhere	2013-12-31	$74
Administrative expenses (other) incurred	2013-12-31	$109,598
Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Value of net income/loss	2013-12-31	$64,862,999
Value of net assets at end of year (total assets less liabilities)	2013-12-31	$519,732,157
Value of net assets at beginning of year (total assets less liabilities)	2013-12-31	$0
Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond)	2013-12-31	No
Were any loans by the plan or fixed income obligations due to the plan in default	2013-12-31	No
Were any leases to which the plan was party in default or uncollectible	2013-12-31	No
Value of interest in registered invesment companies (eg mutual funds) at end of year	2013-12-31	$347,330,648
Value of interest in registered invesment companies (eg mutual funds) at beginning of year	2013-12-31	$0
Interest on participant loans	2013-12-31	$375,889
Value of interest in common/collective trusts at end of year	2013-12-31	$158,185,919
Value of interest in common/collective trusts at beginning of year	2013-12-31	$0
Net investment gain/loss from registered investment companies (e.g. mutual funds)	2013-12-31	$39,392,310
Net investment gain or loss from common/collective trusts	2013-12-31	$11,325,660
Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets	2013-12-31	No
Was there a failure to transmit to the plan any participant contributions	2013-12-31	No
Has the plan failed to provide any benefit when due under the plan	2013-12-31	No
Contributions received in cash from employer	2013-12-31	$16,483,978
Employer contributions (assets) at end of year	2013-12-31	$5,010
Employer contributions (assets) at beginning of year	2013-12-31	$0
Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers	2013-12-31	$33,223,516
Did the plan have assets held for investment	2013-12-31	Yes
Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser	2013-12-31	No
Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC	2013-12-31	No
Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d)	2013-12-31	Yes
Opinion of an independent qualified public accountant for this plan	2013-12-31	Disclaimer
Accountancy firm name	2013-12-31	BROWN SMITH WALLACE LLC
Accountancy firm EIN	2013-12-31	431001367

Form 5500 Responses for MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN

2019: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2019 form 5500 responses
2019-01-01	Type of plan entity	Single employer plan
2019-01-01	Submission has been amended	No
2019-01-01	This submission is the final filing	No
2019-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2019-01-01	Plan is a collectively bargained plan	Yes
2019-01-01	Plan funding arrangement – Trust	Yes
2019-01-01	Plan benefit arrangement - Trust	Yes
2018: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2018 form 5500 responses
2018-01-01	Type of plan entity	Single employer plan
2018-01-01	Submission has been amended	No
2018-01-01	This submission is the final filing	No
2018-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2018-01-01	Plan is a collectively bargained plan	Yes
2018-01-01	Plan funding arrangement – Trust	Yes
2018-01-01	Plan benefit arrangement - Trust	Yes
2017: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2017 form 5500 responses
2017-01-01	Type of plan entity	Single employer plan
2017-01-01	Submission has been amended	No
2017-01-01	This submission is the final filing	No
2017-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2017-01-01	Plan is a collectively bargained plan	Yes
2017-01-01	Plan funding arrangement – Trust	Yes
2017-01-01	Plan benefit arrangement - Trust	Yes
2016: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2016 form 5500 responses
2016-01-01	Type of plan entity	Single employer plan
2016-01-01	Submission has been amended	No
2016-01-01	This submission is the final filing	No
2016-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2016-01-01	Plan is a collectively bargained plan	Yes
2016-01-01	Plan funding arrangement – Trust	Yes
2016-01-01	Plan benefit arrangement - Trust	Yes
2015: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2015 form 5500 responses
2015-01-01	Type of plan entity	Single employer plan
2015-01-01	Submission has been amended	No
2015-01-01	This submission is the final filing	No
2015-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2015-01-01	Plan is a collectively bargained plan	Yes
2015-01-01	Plan funding arrangement – Trust	Yes
2015-01-01	Plan benefit arrangement - Trust	Yes
2014: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2014 form 5500 responses
2014-01-01	Type of plan entity	Single employer plan
2014-01-01	Submission has been amended	No
2014-01-01	This submission is the final filing	No
2014-01-01	This return/report is a short plan year return/report (less than 12 months)	No
2014-01-01	Plan is a collectively bargained plan	Yes
2014-01-01	Plan funding arrangement – Trust	Yes
2014-01-01	Plan benefit arrangement - Trust	Yes
2013: MALLINCKRODT PHARMACEUTICALS RETIREMENT SAVINGS AND INVESTMENT PLAN 2013 form 5500 responses
2013-04-01	Type of plan entity	Single employer plan
2013-04-01	First time form 5500 has been submitted	Yes
2013-04-01	Submission has been amended	No
2013-04-01	This submission is the final filing	No
2013-04-01	This return/report is a short plan year return/report (less than 12 months)	Yes
2013-04-01	Plan is a collectively bargained plan	Yes
2013-04-01	Plan funding arrangement – Trust	Yes
2013-04-01	Plan benefit arrangement - Trust	Yes

Potentially related plans

Was this data useful?

If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. By linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us. Please use the share buttons. It will only take a few seconds of your time. Thanks for helping

Information Disclaimer

The information provided on this website is not advice, endorsement or recommendation
The information published is supplied by third parties so we make no warranty on the accuracy, completeness etc. This information is provided "as-is". The information is subject to change as we obtain updates and corrections from the primary information sources.
You are free to use the information for your own personal research on the understanding to do so is at your own risk.

See full terms and conditions

Company Name:	MALLINCKRODT ENTERPRISES, LLC
Employer identification number (EIN):	364679061
NAIC Classification:	325410

Jurisdiction of Incorporation:	State of Delaware Division of Corporations
Incorporation Date:
Company Identification Number:	4875808